Loading...
Market
Increase in Federal Funding for Marijuana Research Post-Reclassification
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Federal budget allocations or statements from relevant federal agencies
Story
Biden Administration to Reclassify Marijuana as Schedule III Drug Amid DEA Opposition
May 20, 2024, 07:57 PM
President Biden's administration has announced plans to reclassify marijuana as a Schedule III drug, which is considered less dangerous. This move could make marijuana easier to study, although some research barriers will remain. The reclassification is seen as a step towards modernizing outdated cannabis laws in the United States. However, the decision has faced opposition from the Drug Enforcement Administration (DEA), with DEA chief Anne Milgram reportedly refusing to sign off on the change in March. The reclassification could also have significant implications for the marijuana industry. Biden's campaign says the move 'smokes' Trump's marijuana policy.
View original story
Similar markets
Yes • 50%
No • 50%
Increase in pro-marijuana state laws • 33%
No significant change in state laws • 34%
Restrictive state laws enacted • 33%